Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years

Title
Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 8, Issue 9, Pages 1259-1271
Publisher
Informa UK Limited
Online
2012-08-20
DOI
10.4161/hv.21224

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started